Home › Compare › LSBPW vs EQR

LSBPW vs EQR: Dividend Comparison 2026

LSBPW yields 19607.84% · EQR yields 5.87%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 LSBPW wins by $43116657640611241984.00M in total portfolio value
10 years
LSBPW
LSBPW
● Live price
19607.84%
Share price
$0.01
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$43116657640611241984.00M
Annual income
$42,688,387,590,704,500,000,000,000.00
Full LSBPW calculator →
EQR
EQR
● Live price
5.87%
Share price
$59.15
Annual div
$3.47
5Y div CAGR
15.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$47.8K
Annual income
$5,475.61
Full EQR calculator →

Portfolio growth — LSBPW vs EQR

📍 LSBPW pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodLSBPWEQR
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, LSBPW + EQR cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
LSBPW pays
EQR pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

LSBPW
Annual income on $10K today (after 15% tax)
$1,666,666.67/yr
After 10yr DRIP, annual income (after tax)
$36,285,129,452,098,824,000,000,000.00/yr
EQR
Annual income on $10K today (after 15% tax)
$499.01/yr
After 10yr DRIP, annual income (after tax)
$4,654.27/yr
At 15% tax rate, LSBPW beats the other by $36,285,129,452,098,824,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of LSBPW + EQR for your $10,000?

LSBPW: 50%EQR: 50%
100% EQR50/50100% LSBPW
Portfolio after 10yr
$21558328820305620992.00M
Annual income
$21,344,193,795,352,250,000,000,000.00/yr
Blended yield
99.01%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on EQR right now

LSBPW
No analyst data
Altman Z
-2.9
Piotroski
2/9
EQR
Analyst Ratings
16
Buy
28
Hold
2
Sell
Consensus: Hold
Price Target
$70.35
+18.9% upside vs current
Range: $63.00 — $78.50
Altman Z
1.8
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

LSBPW buys
0
EQR buys
0
No recent congressional trades found for LSBPW or EQR in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricLSBPWEQR
Forward yield19607.84% ✓5.87%
Annual dividend / share$2.00$3.47 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%15.8% ✓
Portfolio after 10y$43116657640611241984.00M ✓$47.8K
Annual income after 10y$42,688,387,590,704,500,000,000,000.00 ✓$5,475.61
Total dividends collected$43088394752836018176.00M ✓$23.0K
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: LSBPW vs EQR ($10,000, DRIP)

YearLSBPW PortfolioLSBPW Income/yrEQR PortfolioEQR Income/yrGap
1← crossover$1,971,484$1,960,784.31$11,380$679.82+$1.96M → LSBPW
2$363,385,705$361,276,216.55$13,014$837.25+$363.37M → LSBPW
3$62,623,165,419$62,234,342,714.74$14,961$1,036.20+$62623.15M → LSBPW
4$10,090,370,899,857$10,023,364,112,859.02$17,297$1,289.22+$10090370.88M → LSBPW
5$1,520,188,000,252,008$1,509,391,303,389,160.20$20,121$1,613.15+$1520188000.23M → LSBPW
6$214,150,725,551,759,100$212,524,124,391,489,440.00$23,561$2,030.84+$214150725551.74M → LSBPW
7$28,209,076,706,944,060,000$27,979,935,430,603,678,000.00$27,783$2,573.54+$28209076706944.03M → LSBPW
8$3,474,731,797,968,986,000,000$3,444,548,085,892,556,000,000.00$33,013$3,284.39+$3474731797968986.00M → LSBPW
9$400,252,383,090,414,000,000,000$396,534,420,066,587,160,000,000.00$39,547$4,223.51+$400252383090414016.00M → LSBPW
10$43,116,657,640,611,245,000,000,000$42,688,387,590,704,500,000,000,000.00$47,791$5,475.61+$43116657640611241984.00M → LSBPW

LSBPW vs EQR: Complete Analysis 2026

LSBPW — Stock

LakeShore Biopharma Co., Ltd., a biopharmaceutical company, engages in discovering, developing, manufacturing, and commercializing of vaccines and therapeutic biologics for infectious diseases and cancer. The company develops a proprietary PIKA immunomodulating technology platform and a series of product targeting PIKA rabies vaccine, PIKA recombinant COVID-19 vaccine, and PIKA YS-ON-001. It operates in China, the United States, Singapore, the United Arab Emirates, and the Philippines. The company was formerly known as YS Biopharma Co., Ltd. and changed its name to LakeShore Biopharma Co., Ltd in May 2024. LakeShore Biopharma Co., Ltd was founded in 2002 and is based in Beijing, China.

Full LSBPW Calculator →

EQR — REIT

Equity Residential is committed to creating communities where people thrive. The Company, a member of the S&P 500, is focused on the acquisition, development and management of residential properties located in and around dynamic cities that attract high quality long-term renters. Equity Residential owns or has investments in 305 properties consisting of 78,568 apartment units, located in Boston, New York, Washington, D.C., Seattle, San Francisco, Southern California and Denver.

Full EQR Calculator →
📬

Get this LSBPW vs EQR comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

LSBPW vs SCHDLSBPW vs JEPILSBPW vs OLSBPW vs KOLSBPW vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.